Cowen & Co. Maintains Outperform on Boston Scientific, Raises Price Target to $52

Cowen & Co. analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $47 to $52.

Benzinga · 12/30/2019 11:21

Cowen & Co. analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $47 to $52.